个人简介
Antonino Giordano 医生是米兰圣拉斐尔医院神经科和多发性硬化症中心的神经科顾问,该中心由 Massimo Filippi 教授领导,同时他也是米兰 Vita-Salute San Raffaele 大学医学-神经学领域的固定期限研究员。他还与圣彼得综合医院的神经科合作。
在 Vita-Salute San Raffaele 大学完成神经学专科后,他进入了国际分子医学博士项目,研究焦点为遗传、表观遗传和环境因素在多发性硬化症中的作用。在此期间,他还曾在瑞典斯德哥尔摩的卡罗林斯卡学院神经免疫学科从事海外研究工作。
他的临床工作专注于多发性硬化症及其他中枢神经系统自身免疫性疾病的诊断与治疗。
Giordano 医生的研究工作致力于揭示多发性硬化症及其临床表现的发病机制,重点研究分子与遗传因素,并探索新的潜在治疗方案。
教育背景
巴勒莫大学
医学与外科学士学位 – 2014 年
Vita-Salute 圣拉斐尔大学
神经病学专业 – 2019 年
Vita-Salute 圣拉斐尔大学
分子医学博士(方向:神经科学与实验神经病学)– 2023 年
出版物
最新出版物
BDNF Val66Met polymorphism is associated with motor recovery after rehabilitation in progressive multiple sclerosis patients.
Front Neurology. 2022 Feb 21. doi: 10.3389/fneur.2022.790360.
COVID-19: can we learn from encephalitis lethargica?
Lancet Neurol, 2020.
Diagnosing autoimmune encephalitis in a real-world single center setting.
J Neurol. 2020 Feb;267(2):449-460.
Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report.
Neurol Sci. 2021 Oct;42(10):3969-3971.
Assessing seasonal dynamics of Guillain-Barré syndrome with search engine query data.
Neurol Sci. 2019 May;40(5):1015-1018.
Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report.
Mult Scler Relat Disord. 2018 Aug;24:69-71.
Teaching NeuroImages: Osteolytic intraosseous meningioma causing transcalvarial herniation.
Neurology. 2020 Aug 25;95(8):e1110-e1111.
Involvement of NINJ2 Protein in Inflammation and Blood–Brain Barrier Transmigration of Monocytes in Multiple Sclerosis.
Genes 2022, 13, 1946.
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm. 2023 Feb 15;10(3):e200093.
Early use of fingolimod is associated with better clinical outcomes in relapsing-remitting multiple sclerosis patients.
J Neurol. 2022 Oct;269(10):5596-5605.
Association between inflammatory central nervous system lesions and Cerebellar Ataxia, Neuropathy and Vestibular Areflexia Syndrome (CANVAS): a case series.
J Neurol. 2022 Oct;269(10):5668-5673.
HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis.
Neurol Sci. 2022 Jan 9.
Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review.
J Neurol. 2020 Aug;267(8):2462-2468.
Upper limb motor evoked potentials as outcome measure in progressive multiple sclerosis.
Clin Neurophysiol. 2020 Feb;131(2):401-405.
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family.
Mult Scler Relat Disord. 2018 Jul 24;25:73-76.